The primary purpose of this study was to evaluate analgesic efficacy and safety of
hydrocodone/acetaminophen extended release compared to placebo in the treatment of moderate
to severe pain following bunionectomy.
Phase:
Phase 2
Details
Lead Sponsor:
AbbVie (prior sponsor, Abbott)
Treatments:
Acetaminophen Acetaminophen, hydrocodone drug combination Hydrocodone Oxycodone